Cargando…
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
Insulin resistance (IR) contributes to the pathophysiology of diabetes, dementia, viral infection, and cardiovascular disease. Drug repurposing (DR) may identify treatments for IR; however, barriers include uncertainty whether in vitro transcriptomic assays yield quantitative pharmacological data, o...
Autores principales: | Timmons, James A, Anighoro, Andrew, Brogan, Robert J, Stahl, Jack, Wahlestedt, Claes, Farquhar, David Gordon, Taylor-King, Jake, Volmar, Claude-Henry, Kraus, William E, Phillips, Stuart M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763401/ https://www.ncbi.nlm.nih.gov/pubmed/35037854 http://dx.doi.org/10.7554/eLife.68832 |
Ejemplares similares
-
Amplifying gene expression with RNA-targeted therapeutics
por: Khorkova, Olga, et al.
Publicado: (2023) -
Natural antisense transcripts as drug targets
por: Khorkova, Olga, et al.
Publicado: (2022) -
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018) -
A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease
por: Timmons, James A, et al.
Publicado: (2018) -
Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq
por: Stokes, Tanner, et al.
Publicado: (2023)